David Martínez-Cuadrón Selected Research

David Martínez-Cuadrón Research Topics

Disease

36	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2023 - 09/2011
3	Neoplasms (Cancer) 01/2022 - 01/2016
2	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2021 - 11/2014
2	Leukemia 01/2021 - 12/2013
2	Acute Promyelocytic Leukemia 05/2020 - 01/2020
2	Mycoses (Diseases, Fungus) 09/2019 - 07/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2023
1	Breast Neoplasms (Breast Cancer) 02/2023
1	Trisomy (Trisomies) 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 08/2021
1	Sepsis (Septicemia) 08/2021
1	Pneumonia (Pneumonitis) 08/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2020
1	Febrile Neutropenia 03/2020
1	Disease Progression 03/2020
1	Aspergillosis 03/2020
1	Philadelphia Chromosome 06/2019
1	Heart Failure 07/2017
1	Cardiomyopathies (Cardiomyopathy) 07/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 11/2014
1	Neutropenia 02/2014
1	Bacteremia 02/2014

Drug/Important Bio-Agent (IBA)

11	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2021 - 01/2012
7	AnthracyclinesIBA 01/2021 - 01/2012
4	fludarabineIBA 05/2021 - 01/2018
4	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2018 - 01/2017
3	fms-Like Tyrosine Kinase 3IBA 06/2022 - 01/2021
3	Azacitidine (5 Azacytidine)FDA Link 05/2022 - 01/2021
2	quizartinibIBA 02/2023 - 03/2020
2	gilteritinibIBA 02/2023 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 06/2022 - 11/2020
2	venetoclaxIBA 03/2022 - 01/2021
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2018 - 01/2018
2	plerixafor FDA Link 05/2018 - 01/2018
1	AnionsIBA 02/2023
1	midostaurinIBA 02/2023
1	ponatinibIBA 02/2023
1	crenolanibIBA 02/2023
1	Sorafenib (BAY 43-9006)FDA Link 02/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 02/2023
1	Proteins (Proteins, Gene)FDA Link 02/2023
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2023
1	CPX-351IBA 01/2023
1	Decitabine FDA Link 05/2022
1	Adenosine Triphosphate (ATP)IBA 04/2022
1	Antineoplastic Agents (Antineoplastics)IBA 04/2022
1	Core Binding Factors (Core-Binding Factor)IBA 01/2022
1	SteroidsIBA 08/2021
1	selinexorIBA 06/2021
1	Tyrosine (L-Tyrosine)FDA Link 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Retinoic Acid Receptor alphaIBA 05/2020
1	AzolesIBA 03/2020
1	Arsenic Trioxide (Trisenox)FDA Link 01/2020
1	NucleophosminIBA 10/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 03/2019
1	Cytidine Monophosphate (CMP)IBA 07/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2017
1	Anidulafungin FDA Link 07/2015
1	Antifungal AgentsIBA 07/2015
1	FluoroquinolonesIBA 02/2014
1	Clofarabine (Clolar)FDA Link 01/2014
1	Protein Isoforms (Isoforms)IBA 12/2013

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 05/2023 - 01/2012
8	Therapeutics 04/2023 - 01/2019
6	Induction Chemotherapy 04/2022 - 01/2012
2	Salvage Therapy 06/2021 - 06/2019
2	Transplantation 01/2021 - 11/2014
2	Stem Cell Transplantation 01/2021 - 09/2011
1	Cell Transplantation 01/2023
1	Radiotherapy 01/2022
1	Parenteral Nutrition 08/2021
1	Photopheresis 08/2021
1	Precision Medicine 10/2020
1	Aftercare (After-Treatment) 01/2020
1	Hematopoietic Stem Cell Transplantation 02/2014
1	Total Parenteral Nutrition 02/2014